MedWarn.org
  • Alerts
  • Drugs
    • ADHD Medications
    • Allergy Treatments
    • Antidepressants
    • Antipsychotics
    • Antibiotics
    • Antiseizure
    • Arthritis
    • Cancer Treatments
    • Cardiovascular
    • Diabetes Treatments
    • Dietary Supplements/Weight Loss
    • Erectile Dysfunction
    • Gastrointestinal
    • Hormone Therapy
    • Oral Contraception
    • Pain Relief
    • Respiratory
    • Skin Conditions
    • Sleep
  • Vaccines/Biologics
    • Blood Products
    • Genetic Testing
    • Tissues
    • Vaccines
  • Devices
    • 3D Printed
    • Autoinjectors
    • Brain Devices
    • Breast Implants
    • Cardiac Devices
    • Contraceptive Devices
    • Cyber Security
    • Home Health Devices
    • Hip Implants
    • Infusion Pumps
    • Respiratory Systems
    • Stents
    • Surgical Devices
    • Transvaginal Mesh
  • Tobacco
  • Resources
    • Product Safety and the FDA
    • Product Recalls
    • Product Liability Lawsuits
    • Questions For A Lawyer
    • Get Help
  • About Us

Alerts, Recalls, and Legal Headlines

Sign-up to receive recall notices, medical news, and litigation updates.

SIGN-UP

FDA Committee Recommends Approval of Inhaled Insulin Afrezza

4/2/2014

0 Comments

 
Picture
Yesterday the FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 13 to 1 to recommend approval of Afrezza, a form of insulin that is inhaled rather than injected. Developed by MannKind Corporation, Afrezza would be a new option for millions of diabetics.  Although there were more cases of lung cancer among those who received Afrezza in clinical trials than in control groups, the numbers were small.  Longer-term studies of the risk of long-term exposure of the lungs to insulin would be needed to more definitively assess the risk of lung cancer.  In the past, major pharmaceutical companies Pfizer, Novo Nordisk and Eli Lilly had abandoned efforts to offer inhaled insulin.  The founder of MannKind Corporation, aerospace and medical device entrepreneur Alfred E. Mann, believes that the Afrezza inhaler will be more successful because it is smaller and easier to use than Pfizer's abandoned product Exubera.  In clinical trials, Afrezza was less effective than injected insulin in reducing blood sugar for Type 1 diabetics, but performed marginally better for those with Type 2 diabetes.  MannKind suggested that inhaled insulin would appeal to patients who might otherwise avoid or delay injection insulin treatments.  The panel vote is not binding on the FDA, but the FDA usually follows the panel's recommendation.  
[1] Radick, L. "FDA Panel Says Yes to Inhaled Insulin Device," medpage TODAY (April 1, 2014).
[2] Pollack, A. "Inhaled Insulin Clears Hurdle Toward F.D.A. Approval," The New York Times (April 1, 2014).
[3] Edney, A. "MannKind Wins U.S. Panel Backing for Inhaled Insulin," Bloomberg (April 2, 2014).

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    September 2013
    July 2013
    June 2013
    May 2013
    March 2013
    January 2013
    July 2012
    June 2012
    March 2012
    February 2012
    August 2011
    December 2010
    August 2010
    February 2009
    July 2008

    RSS Feed

    Categories

    All
    3D Printing
    3D Printing
    Acid Reducers
    Acne Treatments
    ADHD
    Allergies
    Antibiotics
    Antidepressants
    Anti-Epilepsy
    Antipsychotics
    Antiviral
    Arthritis
    Aspirin
    Asthma
    Autism
    Birth Control
    Birth Defects
    Blood Products
    Bone
    Brain
    Cancer
    COPD
    Cyber Crime
    Diabetes
    Dietary Supplements
    Dna-testing
    E-cigarettes
    Electronic Health Records
    Eliquis
    Epilepsy
    FDA/Approvals
    FDA Recalls
    FDA/Recalls
    FDA Warnings
    FDA Warnings
    Hearing-devices
    Hearing Loss
    Heart
    Hemophilia
    Hip Implants
    Hormone
    HPV
    Infants
    Infusion Pump
    Invokana
    Legal News
    Migraines
    Mirena
    Monitors
    Multiple Sclerosis
    Pain Relief
    Research
    Resuscitation
    Risperdal
    Sleep
    Stents
    Stroke
    Surgical Device
    Surgical Device
    Topamax
    Transvaginal Mesh
    Vaccine
    Weight Control
    Weight Control

    RSS Feed



    120x600
Need help finding a medical or legal professional?  Email us at info@medwarn.org

Home
About Us
Get Alerts

Privacy Policy
Terms of Use
Get Help
© 2014 MedWarn LLC
Photo used under Creative Commons from Official U.S. Navy Imagery